Bausch + Lomb is acquiring Johnson & Johnson’s Blink line of eye drops. The deal comes as J&J exits the consumer business while Bausch + Lomb expands its product portfolio with its second deal in as many weeks.
Providers and payers will be able to use Uber Health to deliver healthy groceries and over-the-counter items to patients who need them. They'll be able to do this on the same platform they use to request non-emergency medical transportation and prescription delivery.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The main factor behind why women want over-the-counter birth control pills is convenience, the survey found. Of those who are unlikely to use over-the-counter birth control pills — or are unsure if they would —most said it's because they don’t currently use birth control pills or don’t plan to in the future.
When consumer healthcare products joint venture Haleon spins out from GSK as an independent company next month, Pfizer will sell its minority stake in the business. Pfizer said that selling its ownership in Haleon is keeping with its focus on developing innovative new medicines and vaccines.
After the Food and Drug Administration authorized a swathe of over-the-counter tests for Covid-19, pharmacies are preparing to stock their shelves. But at $20 to $100 a pop, will enough people use them to make a difference?
The British drugmaker plans to separate the consumer health joint venture with Pfizer announced Wednesday three years after the transaction closes.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The collaboration will enable Anthem Medicare Advantage members to use over-the-counter plan allowances to buy OTC medications and health-related supplies at Walmart stores and on Walmart.com.
Massachusetts-based Neurometrix just received 510(k) clearance from the Food and Drug Administration for over-the-counter use of its wearable gadget that treats chronic pain. The lightweight device, which is still under development and projected for commercial launch next year, emits electric jolts to the wearer. It is modeled after Sensus, the company’s device that treats pain associated with […]